On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology ...

Panelists discuss how: clinical inertia, patient apathy, and the asymptomatic nature of high cholesterol all contribute to undertreatment and poor outcomes.

Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

The hyperlipidemia drugs market is growing due to rising cardiovascular disease prevalence, increasing cholesterol management awareness, and aging populations. Opportunities lie in personalized and ...

Researchers have uncovered a simple magnesium-based score that could help identify which high-cholesterol patients are most likely to face deadly heart problems, years before symptoms appear. Study: ...

American Journal of Health-System Pharmacy. 2005;62(16):1690-1692. A 62-year-old Caucasian man arrived at an ambulatory care clinic in August 2003 for hyperlipidemia follow-up. One of the patient's ...

What is the significance of asymptomatic CK elevation in combination therapy of hyperlipidemia with statin/Niaspan (niacin extended-release tablets)? I have a patient whose lipids were suboptimally ...

Please provide your email address to receive an email when new articles are posted on . “PCOS patients are at increased risk of metabolic conditions, even patients who were in the non-obese range,” ...

Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia – elevations of triglycerides and cholesterol ...

Medicines use review in renal cancer: How are we doing? What could we do better? Background: To our knowledge effects of sunitinib on serum lipids metabolism are not described. Here we report about ...

Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers have found that only about half ...